annual EBITDA:
$589.48M+$97.04M(+19.71%)Summary
- As of today (August 16, 2025), AMRX annual EBITDA is $589.48 million, with the most recent change of +$97.04 million (+19.71%) on December 31, 2024.
- During the last 3 years, AMRX annual EBITDA has risen by +$131.76 million (+28.79%).
- AMRX annual EBITDA is now at all-time high.
Performance
AMRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$176.93M+$22.34M(+14.45%)Summary
- As of today (August 16, 2025), AMRX quarterly EBITDA is $176.93 million, with the most recent change of +$22.34 million (+14.45%) on June 30, 2025.
- Over the past year, AMRX quarterly EBITDA has increased by +$35.23 million (+24.86%).
- AMRX quarterly EBITDA is now at all-time high.
Performance
AMRX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$583.88M+$35.23M(+6.42%)Summary
- As of today (August 16, 2025), AMRX TTM EBITDA is $583.88 million, with the most recent change of +$35.23 million (+6.42%) on June 30, 2025.
- Over the past year, AMRX TTM EBITDA has increased by +$232.38 million (+66.11%).
- AMRX TTM EBITDA is now at all-time high.
Performance
AMRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AMRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.7% | +24.9% | +66.1% |
| 3 y3 years | +28.8% | +228.8% | +406.9% |
| 5 y5 years | +182.4% | +142.4% | +70.6% |
AMRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.8% | at high | +228.8% | at high | +406.9% |
| 5 y | 5-year | at high | +182.4% | at high | +228.8% | at high | +406.9% |
| alltime | all time | at high | +3097.4% | at high | +191.3% | at high | +1254.0% |
AMRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $176.93M(+14.5%) | $583.88M(+6.4%) |
| Mar 2025 | - | $154.58M(+37.4%) | $548.65M(+24.8%) |
| Dec 2024 | $589.48M(+19.7%) | $112.47M(-19.6%) | $439.77M(+22.1%) |
| Sep 2024 | - | $139.90M(-1.3%) | $360.32M(+2.5%) |
| Jun 2024 | - | $141.70M(+210.0%) | $351.50M(+1.2%) |
| Mar 2024 | - | $45.71M(+38.4%) | $347.43M(-13.1%) |
| Dec 2023 | $492.44M(+11.8%) | $33.02M(-74.8%) | $399.76M(-14.4%) |
| Sep 2023 | - | $131.07M(-4.8%) | $467.17M(+5.6%) |
| Jun 2023 | - | $137.63M(+40.4%) | $442.27M(+164.5%) |
| Mar 2023 | - | $98.04M(-2.4%) | $167.24M(+11.2%) |
| Dec 2022 | $440.61M(-3.7%) | $100.43M(-5.4%) | $150.43M(+16.8%) |
| Sep 2022 | - | $106.18M(-177.3%) | $128.82M(+11.8%) |
| Jun 2022 | - | -$137.41M(-269.2%) | $115.18M(-69.5%) |
| Mar 2022 | - | $81.23M(+3.1%) | $377.99M(-5.8%) |
| Dec 2021 | $457.72M(+16.9%) | $78.82M(-14.8%) | $401.10M(-2.5%) |
| Sep 2021 | - | $92.54M(-26.2%) | $411.21M(+5.2%) |
| Jun 2021 | - | $125.39M(+20.2%) | $391.03M(+15.5%) |
| Mar 2021 | - | $104.34M(+17.3%) | $338.62M(-2.0%) |
| Dec 2020 | $391.70M(+87.6%) | $88.93M(+22.9%) | $345.61M(+18.1%) |
| Sep 2020 | - | $72.36M(-0.8%) | $292.69M(-14.5%) |
| Jun 2020 | - | $72.98M(-34.4%) | $342.17M(+11.3%) |
| Mar 2020 | - | $111.33M(+209.1%) | $307.56M(+98.2%) |
| Dec 2019 | $208.75M | $36.02M(-70.4%) | $155.20M(-20.3%) |
| Sep 2019 | - | $121.84M(+217.6%) | $194.74M(+7.3%) |
| Jun 2019 | - | $38.37M(-193.5%) | $181.51M(-458.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$41.03M(-154.3%) | -$50.60M(-164.7%) |
| Dec 2018 | $438.18M(+50.2%) | $75.57M(-30.4%) | $78.25M(-19.8%) |
| Sep 2018 | - | $108.61M(-156.1%) | $97.56M(+109.7%) |
| Jun 2018 | - | -$193.74M(-320.6%) | $46.51M(-84.4%) |
| Mar 2018 | - | $87.82M(-7.4%) | $297.58M(+41.9%) |
| Dec 2017 | $291.65M(+118.5%) | $94.87M(+64.8%) | $209.76M(+82.6%) |
| Sep 2017 | - | $57.56M(+0.4%) | $114.89M(+100.4%) |
| Jun 2017 | - | $57.33M | $57.33M |
| Dec 2016 | $133.47M(-14.5%) | - | - |
| Dec 2015 | $156.07M(+19.1%) | - | - |
| Dec 2014 | $131.07M(+117.9%) | - | - |
| Dec 2013 | $60.16M(-64.8%) | - | - |
| Dec 2012 | $170.70M(+39.0%) | - | - |
| Dec 2011 | $122.80M(-70.2%) | - | - |
| Dec 2010 | $412.36M(+327.9%) | - | - |
| Dec 2009 | $96.38M(+344.3%) | - | - |
| Dec 2008 | $21.69M(-77.2%) | - | - |
| Dec 2007 | $95.14M(+1045.1%) | - | - |
| Dec 2006 | $8.31M(+10.4%) | - | - |
| Dec 2005 | $7.53M(-200.7%) | - | - |
| Dec 2003 | -$7.48M(-58.6%) | - | - |
| Dec 2002 | -$18.05M(-8.2%) | - | - |
| Dec 2001 | -$19.67M(+24.5%) | - | - |
| Dec 2000 | -$15.80M(+122.0%) | - | - |
| Dec 1999 | -$7.12M(+64.0%) | - | - |
| Dec 1998 | -$4.34M | - | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Amneal Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of AMRX is $589.48M
What is the all time high annual EBITDA for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual EBITDA is $589.48M
What is Amneal Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, AMRX annual EBITDA has changed by +$97.04M (+19.71%)
What is Amneal Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of AMRX is $176.93M
What is the all time high quarterly EBITDA for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly EBITDA is $176.93M
What is Amneal Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, AMRX quarterly EBITDA has changed by +$35.23M (+24.86%)
What is Amneal Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of AMRX is $583.88M
What is the all time high TTM EBITDA for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high TTM EBITDA is $583.88M
What is Amneal Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, AMRX TTM EBITDA has changed by +$232.38M (+66.11%)